Ainsworth Sean 4
4 · Ocuphire Pharma, Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Ainsworth Sean
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-11+35,181→ 35,181 totalExercise: $1.72Exp: 2034-06-10→ Common Stock (35,181 underlying) - Award
Common Stock
2024-06-11+41,143→ 88,358 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
- [F2]The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.